CIENCIASMEDICASNEWS: Health News and Information - News Medical - Alzheimer's Disease

jueves, 29 de marzo de 2018

Health News and Information - News Medical - Alzheimer's Disease - Mar 28, 2018 Edition

Health News and Information - News Medical

	March 28, 2018
	Alzheimer's Disease
	The latest Alzheimer's disease news from News Medical

	Using VR to Go Back in Time for Those Living with Alzheimer's Currently, there are an estimated 46 million people worldwide living with dementia. There is currently no cure, and no way to prevent the onset of dementia. The Wayback Project was created by a group of friends and former colleagues who wanted to create virtual reality films that allow patients to go 'back in time'.

	Transplanting enhanced interneurons restores brain rhythms in mouse model of Alzheimer’s Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer's disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.

			Researchers explain link between 2 key Alzheimer's proteins It's a paradox of Alzheimer's disease: Plaques of the sticky protein amyloid beta are the most characteristic sign in the brain of the deadly neurodegenerative disease. However, many older people have such plaques in their brains but do not have dementia.

			African Americans with thyroid gene variation more likely to develop Alzheimer's African Americans with a common genetic variation are at increased risk for developing Alzheimer's disease, while European Americans with the same variation are not, according to a study led by researchers at Rush University Medical Center.

			Compound found in beet extract could help slow progression of Alzheimer’s disease A compound in beets that gives the vegetable its distinctive red color could eventually help slow the accumulation of misfolded proteins in the brain, a process that is associated with Alzheimer's disease. Scientists say this discovery could lead to the development of drugs that could alleviate some of the long-term effects of the disease, the world's leading cause of dementia.

	Daily regimen of ibuprofen can ward off Alzheimer's disease, say neuroscientists A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enough, a daily regimen of the non-prescription NSAID (nonsteroidal anti-inflammatory drug) ibuprofen can prevent the onset of Alzheimer's disease.

	Antibody sweeps away Alzheimer's plaques in mice Years before people start showing characteristic symptoms of Alzheimer's disease, sticky plaques begin forming in their brains, damaging nearby cells. For decades, doctors have sought ways to clear out these plaques as a way to prevent or treat the disease.

	GlycoNet researchers to study correlation between sugars and Alzheimer's disease Two GlycoNet Investigators are using technology to better understand how sugars in the human body are connected to Alzheimer's disease.

	Study shows importance of family history in onset of Alzheimer's disease You're about to turn 60, and you're fretting. Your mother has had Alzheimer's disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer's, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

	Traumatic brain injuries may increase risk of Alzheimer’s disease earlier in life Concussions and other traumatic brain injuries may increase the risk of developing Alzheimer's disease earlier in life, according to a study from UT Southwestern's Peter O'Donnell Jr. Brain Institute.

	Study findings establish basis for epigenetic link between aging and Alzheimer's disease Although certain genetic variants increase the risk of Alzheimer's disease (AD), age is the strongest known risk factor. But the way in which molecular processes of aging predispose people to AD, or become impaired in AD remains a mystery.

	High protein diet reduces risk of Alzheimer’s disease, research finds A diet high in protein-rich foods such as meat and legumes reduces the risk of developing Alzheimer’s disease, new research from Edith Cowan University has found.

	Mice study raises hope to successfully treat Alzheimer's disease A team of researchers from the Cleveland Clinic Lerner Research Institute have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer's disease, thereby improving the animals' cognitive function.

	Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.

	Inadequate oxygen levels during sleep increase risk of developing Alzheimer's disease Inadequate oxygen levels during sleep can damage the brain and increase the risk of developing Alzheimer's disease, University of Queensland researchers have found.

	Discovery sheds new light on pathology of Alzheimer's disease An association between inflammation biomarkers in both blood plasma and cerebrospinal fluid and markers of Alzheimer's disease associated pathology, has been found by researchers at the University of Colorado Anschutz Medical Campus working with the University of Wisconsin Alzheimer's Disease Research Center and the University of California San Francisco Memory and Aging Center.

	Stigma associated with Alzheimer's may prevent people from getting early diagnosis, treatment Stigma associated with Alzheimer's disease may be an obstacle for individuals to seek information about their risk of developing Alzheimer's disease and to participate in clinical studies that discover potential therapies.

	Long-term PPI use not linked to increased hip fracture risk among Alzheimer's patients $Long-term PPI use not linked to increased hip fracture risk among Alzheimer's patients$ Long-term proton pump inhibitor (PPI) use does not increase the risk of hip fracture among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.

	Initiating opioid analgesic decreases use of antipsychotics, benzodiazepines in Alzheimer's patients Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease, a recent study from the University of Eastern Finland shows.

	Alzheimer’s disease on the rise A new report shows that Alzheimer’s disease cases and the costs of treatment and hospitalization due to this disease and deaths due to this condition are on the rise. The report finds that at present 5.7 million Americans suffer from Alzheimer’s disease and of these 5.5 million are over the age of 65 years. Of these 3.4 million are women.

	Alzheimer’s Research UK calls for new approach to prevent delay in future dementia treatments New analysis from Alzheimer’s Research UK shows the UK health system will need to think differently to cope with the unique challenges presented by future dementia treatments.

	Feeling sleepy during the day could predict Alzheimer's disease finds study In a new study, researchers have shown that excessive sleepiness during the day time among elderly who had normal mental acuity and cognitive powers is associated with the buildup of amyloid plaques in the brain that is typical of Alzheimer’s disease.

	Common genetic variation shown to increase Alzheimer’s risk A recent study has found that African Americans with a common genetic variation are at an increased risk for developing Alzheimer’s disease.

	Researchers explore how people with Alzheimer's disease use end-of-life medical services Because people are now living longer and often healthier lives, the rate of some illnesses that are more likely to develop with age has risen. These illnesses include dementia. In fact, the number of us living with dementia was already 47 million worldwide in 2015. It could reach 131 million by 2050.

	Alzheimer’s study on mice reveals important mechanism behind neural hyperactivity Alzheimer´s disease is the key cause of dementia in elderly patients. Those affected develop deficiencies in their abilities to learn, think logically, communicate, and to master the challenges of everyday life.

	Boosting the brain's immune cells may prevent or reduce severity of Alzheimer's disease Sanford Burnham Prebys Medical Research Institute researchers have published two new studies in Neuron that describe how TREM2, a receptor found on immune cells in the brain, interacts with toxic amyloid beta proteins to restore neurological function.

	Concordia study focuses on effects of bilingualism for patients with Alzheimer's disease After more than a decade of research, this much we know: it's good for your brain to know another language.

	Study describes new protection mechanisms to fight neurodegeneration in Parkinson's and Alzheimer's A new research study reveals RAC1 protein could be a new therapeutic target to study the molecular mechanisms related to the neurodegenerative processes in Parkinson's disease.

	Alzheimer's disease also affects small blood vessels A research conducted by the UAB demonstrates that mice suffering from this disease also have substantial malfunctions in small blood vessels, important in nourishing different organs and tissues and in regulating blood pressure, and which mainly affects females.

	Verb fluency test may be useful tool for differential diagnosis of cognitive failure The ability to generate spoken verbs in infinitive in a given time begins to worsen in the early stages of Alzheimer's disease (AD).

	AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.

	Scientists demonstrate successful implementation of prosthetic memory system Scientists at Wake Forest Baptist Medical Center and the University of Southern California (USC) have demonstrated the successful implementation of a prosthetic system that uses a person's own memory patterns to facilitate the brain's ability to encode and recall memory.

	Neuroscientists move closer to developing tools for deciphering brain function A team of University of Missouri neuroscientists are inching closer to developing the tools needed to decipher the brain.

	Social interaction could enhance dementia care, finds study Increasing social interaction among people living with dementia in care homes could improve the quality of their life and save money, suggests new study.

	Scientists design new triple labeling technique to analyze stem cell division A joint team of scientists from Russia and the United States designed a method for marking dividing stem cells with three different labels.